Latest News

Can a Racial Divide Explain Non-Treatment of HCV among the HIV-HCV Coinfected?
BY JENNIFER G. ALLEN
Study finds a common assortment of reasons for non-initiation of HCV therapy, regardless of patient race or ethnicity.
Monitoring Infants for Hepatitis C Virus
BY JENNIFER G. ALLEN
Managing the risk of hepatitis C and liver disease among infants born to mothers with chronic HCV is a challenge.
Chronic Hepatitis C Increases Risk of Death in Patients Admitted to ICU
BY LAUREN SANTYE, ASSISTANT EDITOR
HCV patients with cirrhosis and severe sepsis face elevated risk of organ failure.
Black Plague Reveals Clues for Fighting Hepatitis C
BY LAUREN SANTYE, ASSISTANT EDITOR
Anti-retroviral drug therapy may effectively treat hepatitis C-HIV coinfection.
Keeping Up With Advances in Hepatitis C Treatment
BY JENNIFER G. ALLEN
Antiviral therapies are changing the clinical landscape for the treatment of HCV in developed countries.
Prior Authorization Creates Hurdle in Hepatitis C Treatment
BY JENNIFER G. ALLEN
Patient access to curative hepatitis C medications remains a challenge.
Researchers Examine New Hepatitis C Treatment Models with High Cost Drugs
BY LAUREN SANTYE, ASSISTANT EDITOR
Study predicts when an HCV cure was achieved and predicts when therapy should be discontinued.
Liver Cancer Rates Associated with Hepatitis C Increases
BY CATHERINE KOLONKO
In the US, the incidence of liver cancer rose an average of 2.3% each year overall from 2008 to 2012.
$auto_registration$